BioXcel Therapeutics, Inc. (BTAI)
1.60
-0.05
(-3.03%)
USD |
NASDAQ |
Mar 05, 16:00
1.55
-0.05
(-3.12%)
After-Hours: 20:00
BioXcel Therapeutics Free Cash Flow : -58.21M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Rigel Pharmaceuticals, Inc. | 75.66M |
| Puma Biotechnology, Inc. | 41.73M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Savara, Inc. | -99.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.79M |
| Cash from Financing (Quarterly) | 37.53M |
| Free Cash Flow Per Share (Quarterly) | -1.323 |
| Free Cash Flow to Equity (Quarterly) | -19.13M |
| Free Cash Flow to Firm (Quarterly) | -14.41M |
| Free Cash Flow Yield | -486.5% |